Does CYTARABINE Cause Diffuse large b-cell lymphoma refractory? 193 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 193 reports of Diffuse large b-cell lymphoma refractory have been filed in association with CYTARABINE (cytarabine). This represents 0.4% of all adverse event reports for CYTARABINE.
193
Reports of Diffuse large b-cell lymphoma refractory with CYTARABINE
0.4%
of all CYTARABINE reports
32
Deaths
50
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From CYTARABINE?
Of the 193 reports, 32 (16.6%) resulted in death, 50 (25.9%) required hospitalization, and 19 (9.8%) were considered life-threatening.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CYTARABINE. However, 193 reports have been filed with the FAERS database.
What Other Side Effects Does CYTARABINE Cause?
Febrile neutropenia (6,142)
Off label use (4,183)
Pyrexia (2,992)
Neutropenia (2,558)
Disease progression (2,352)
Drug ineffective (2,281)
Thrombocytopenia (2,148)
Sepsis (2,013)
Myelosuppression (1,869)
Product use in unapproved indication (1,619)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
DEXAMETHASONE (170)
CISPLATIN (156)
IFOSFAMIDE (154)
Which CYTARABINE Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
CYTARABINE vs CYTARABINE\DAUNORUBICIN
CYTARABINE vs DABIGATRAN
CYTARABINE vs DABIGATRAN ETEXILATE
CYTARABINE vs DABRAFENIB
CYTARABINE vs DABRAFENIB\TRAMETINIB